獣医用リファレンスラボ市場規模、シェア、動向、2030年までの世界予測

獣医用リファレンスラボ市場 – サービス（微生物学、免疫診断、分子診断、PCR、ELISA、血液学、尿検査）、動物（コンパニオン、家畜）、アプリケーション（臨床病理学、毒物学）、地域別 – 2030年までの世界予測

獣医用リファレンスラボ市場は、2025年の475万米ドルから2030年には646万米ドルに拡大し、年平均成長率（CAGR）6.3%を記録すると予測されています。人獣共通感染症および慢性動物疾患の蔓延、ペット飼育数の増加、そして予防医療への重点化が、市場拡大の主な原動力となっています。分子診断、免疫診断、臨床化学といった高度な診断検査への需要の高まりにより、先進地域と新興地域の両方で、ハイスループットのリファレンスラボの設立が加速しています。さらに、自動化、AIベースの画像解析、分子検査における技術の進歩により、ターンアラウンドタイムの​​短縮と診断精度の向上が可能になり、獣医師とペットオーナーの信頼が高まっています。

調査範囲

本レポートは、獣医用リファレンスラボ市場をサービス、用途、動物種、エンドユーザー、地域の観点から分析しています。また、市場の成長に影響を与える要因（促進要因、阻害要因、機会、課題）についても調査しています。市場の機会と課題を分析し、市場リーダーの競争環境の詳細を提供しています。さらに、マイクロマーケットを個々の成長傾向の観点から分析し、主要6地域および各国における市場セグメントの収益予測も示しています。

レポートを購入する理由

本レポートは、既存企業だけでなく、新興企業や小規模企業も市場動向を把握し、より大きな市場シェアを獲得するのに役立ちます。本レポートを購入した企業は、以下に示す5つの戦略のうち、1つ以上を活用できます。

本レポートは、以下の点について洞察を提供します。

• 獣医用リファレンスラボ市場の成長に影響を与える主要な推進要因、機会、制約、課題の分析。
• 製品開発／イノベーション：獣医リファレンスラボ市場における今後の技術、研究開発活動、サービス開始に関する詳細な洞察。
• 市場開発：成長性の高い新興市場に関する包括的な情報。本レポートは、様々な地域における様々なタイプの獣医用リファレンスラボサービスの市場を分析しています。
• 市場の多様化：獣医用リファレンスラボ市場における製品、未開拓地域、最近の動向、投資に関する包括的な情報。
• 競合評価：獣医用リファレンスラボ市場における主要企業の市場シェア、戦略、製品、流通ネットワーク、製造能力に関する詳細な評価。

Report Description

The veterinary reference laboratory market is forecasted to grow from USD 4.75 million in 2025 to USD 6.46 million by 2030, recording a CAGR of 6.3%. The increasing prevalence of zoonotic and chronic animal diseases, rising companion animal ownership, and the growing emphasis on preventive healthcare primarily drive market expansion. The rising demand for advanced diagnostic testing, including molecular diagnostics, immunodiagnostics, and clinical chemistry, has accelerated the establishment of high-throughput reference laboratories in both developed and emerging regions. Moreover, technological advancements in automation, AI-based image analysis, and molecular testing are enabling faster turnaround times and improved diagnostic accuracy, fostering greater trust among veterinarians and pet owners.

At the same time, the increasing integration of diagnostic services with digital platforms and laboratory information management systems (LIMS) is streamlining workflows, enhancing sample traceability, and enabling remote access to test results. The rising focus on early disease detection and companion animal wellness programs further supports test adoption, while expanding veterinary corporatization and partnerships between clinics and reference labs are driving consistent sample inflows. However, the market faces challenges such as high operational and testing costs, a shortage of skilled laboratory professionals, and stringent regulatory standards governing veterinary diagnostics. Additionally, maintaining quality assurance across diverse geographies and addressing biosecurity and sample transport challenges remain key priorities for laboratories aiming to sustain accuracy, reliability, and growth momentum.

The clinical pathology segment accounted for the largest share of the market, by application, in 2024.

Based on application, the veterinary reference laboratory market is segmented into clinical pathology, bacteriology, virology, parasitology, and other applications. In 2024, clinical pathology accounted for the largest share of the market. This dominance is attributed to the segment’s critical role in delivering detailed diagnostic insights through hematology, cytology, and clinical chemistry testing. These analyses enable veterinarians to accurately diagnose systemic disorders, track therapeutic progress, and effectively manage complex disease conditions. The rising companion animal population and increasing frequency of veterinary consultations have fueled the demand for routine pathology services. Moreover, technological advancements in automated analyzers and digital pathology systems have significantly improved diagnostic precision, efficiency, and turnaround time, further driving market growth in this segment.

The veterinary clinics & hospitals segment is expected to dominate the market, by end user, during the forecast period.

Based on end user, the veterinary reference laboratory market is segmented into veterinary clinics and hospitals, research institutes and universities, point-of-care/in-house labs, and other end users. In 2024, veterinary clinics and hospitals accounted for the largest share of the global market. This dominance is primarily driven by the rising volume of diagnostic testing conducted through referral partnerships with centralized laboratories, as clinics increasingly outsource advanced and specialized tests such as molecular diagnostics, immunodiagnostics, and clinical chemistry to improve diagnostic accuracy and efficiency.

The growing companion animal population, higher pet healthcare expenditure, and expanding network of small and large veterinary practices have further contributed to the rising sample inflow from clinics and hospitals. These facilities rely on reference laboratories for confirmatory and complex testing that cannot be efficiently performed in-house, thereby enhancing treatment outcomes and operational workflows. Additionally, the integration of digital sample management systems and automated result reporting between clinics and reference labs is improving turnaround times and supporting evidence-based veterinary care.

In 2024, North America dominated the veterinary reference laboratory market.

The veterinary reference laboratory market is segmented into North America, Europe, Asia Pacific, and the Middle East & Africa. In 2024, North America accounted for the largest share of the global market. This dominance can be attributed to several key factors, including the high prevalence of companion animal ownership, strong awareness of preventive veterinary care, and significant healthcare expenditure on pets across the region. The presence of leading industry players such as IDEXX Laboratories, Zoetis Services LLC, and Mars, Incorporated, coupled with a well-established network of veterinary hospitals and diagnostic centers, has further reinforced the region’s leadership. Within North America, the United States held the largest market share, supported by the country’s advanced veterinary infrastructure, growing demand for specialized and molecular diagnostic testing, and rapid adoption of automation and digital pathology solutions. Additionally, the U.S. market benefits from favorable pet insurance penetration, a robust ecosystem of veterinary service providers, and strong investment in R&D for companion and livestock diagnostic innovations.

Breakdown of supply-side primary interviews:

• By Company Type: Tier 1 (45%), Tier 2 (20%), and Tier 3 (35%)
• By Designation: C-level Executives (35%), Directors (25%), and Other Designations (40%)
• By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and Middle East & Africa (5%)

Breakdown of demand-side primary interviews:

• By Company Type: Veterinary Clinics & Hospitals (70%), POC/In-house labs (15%), Research Institutions and Universities (10%), and Other End Users (5%)
• By Designation: Veterinary Healthcare Professionals (35%), Department Heads (27%), Procurement Heads (22%), and Other Designations (16%)
• By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and Middle East & Africa (5%)

Research Coverage

This report studies the veterinary reference laboratory market based on service, application, animal type, end user, and region. It also studies factors affecting market growth (drivers, restraints, opportunities, and challenges). It analyzes the market’s opportunities and challenges and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to six main regions and respective countries.

Reasons to Buy the Report

The report can help established companies and new or smaller firms understand market trends, which will help them capture a larger market share. Firms that purchase the report can utilize one or more of the five strategies mentioned below.

This report provides insights into the following points:

• Analysis of key drivers, opportunities, restraints, and challenges influencing the growth of the veterinary reference laboratory market.
• Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and service launches in the veterinary reference laboratory market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of veterinary reference laboratory services across regions.
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the veterinary reference laboratory market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the veterinary reference laboratory market.

Table of Contents

1               INTRODUCTION              48

1.1           STUDY OBJECTIVES       48

1.2           MARKET DEFINITION   48

1.3           STUDY SCOPE   48

1.3.1        MARKET SEGMENTATION           49

1.3.2        REGIONAL SCOPE            50

1.3.3        INCLUSIONS & EXCLUSIONS       50

1.3.4        YEARS CONSIDERED      51

1.4           MARKET STAKEHOLDERS            51

1.5           SUMMARY OF CHANGES               52

2               RESEARCH METHODOLOGY       54

2.1           RESEARCH DATA              54

2.2           RESEARCH METHODOLOGY DESIGN     54

2.2.1        SECONDARY DATA          55

2.2.1.1    Key sources of secondary research     55

2.2.1.2    Key objectives of secondary research                 56

2.2.1.3    Key data from secondary sources       57

2.2.2        PRIMARY DATA 57

2.2.2.1    Key primary sources             58

2.2.2.2    Key objectives of primary research    58

2.2.2.3    Key data from primary sources           59

2.2.2.4    Key industry insights           60

2.3           MARKET SIZE ESTIMATION         62

2.3.1        REVENUE SHARE ANALYSIS         62

2.3.2        COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS      64

2.3.3        DEMAND-SIDE ANALYSIS             64

2.3.4        TOP-DOWN APPROACH                65

2.3.5        BOTTOM-UP APPROACH              66

2.4           DATA TRIANGULATION                68

2.5           MARKET SHARE ANALYSIS           69

2.6           STUDY ASSUMPTIONS  70

2.6.1        MARKET ASSUMPTIONS               70

2.6.2        GROWTH RATE ASSUMPTIONS 70

2.7           RISK ANALYSIS  71

2.8           RESEARCH LIMITATIONS             71

2.8.1        METHODOLOGY-RELATED LIMITATIONS           71

2.8.2        SCOPE-RELATED LIMITATIONS                 71

3               EXECUTIVE SUMMARY  72

4               PREMIUM INSIGHTS       78

4.1           VETERINARY REFERENCE LABORATORY MARKET OVERVIEW          78

4.2           ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET,

BY PRODUCT AND COUNTRY (2024)       79

4.3           VETERINARY REFERENCE LABORATORY MARKET: REGIONAL MIX 80

4.4           VETERINARY REFERENCE LABORATORY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES            80

4.5           VETERINARY REFERENCE LABORATORY MARKET: DEVELOPED VS.

EMERGING ECONOMIES               81

5               MARKET OVERVIEW       82

5.1           MARKET DYNAMICS       83

5.1.1        DRIVERS               83

5.1.1.1    Growing routine wellness and oncology screening in

companion animals               83

5.1.1.2    Rapid adoption of digital pathology and telepathology  84

5.1.1.3    Increasing prevalence/awareness of zoonotic and emerging diseases  85

5.1.1.4    Growth in companion animal population         87

5.1.1.5    Rising demand for animal-derived food products           90

5.1.1.6    Increasing demand for pet insurance and growing animal

health expenditure                90

5.1.2        RESTRAINTS      92

5.1.2.1    Competition from in-clinic and point-of-care testing    92

5.1.2.2    High capital investment and fixed cost burden in veterinary reference laboratories          92

5.1.3        OPPORTUNITIES              93

5.1.3.1    Potential growth opportunities in emerging economies 93

5.1.3.2    Investment in advanced technologies in veterinary reference laboratories            94

5.1.4        CHALLENGES    95

5.1.4.1    Competitive pressure and margin pressure in veterinary reference laboratories          95

5.1.4.2    Data privacy, biosecurity, and sample ownership in veterinary reference laboratories          95

5.2           INDUSTRY TRENDS         96

5.2.1        DIGITAL PATHOLOGY, TELECYTOLOGY, AND AI FROM PILOT TO COMMERCIAL SERVICES         96

5.2.2        CONTINUED CONSOLIDATION AND VERTICAL INTEGRATION ACROSS ANIMAL-HEALTH ECOSYSTEM 97

5.3           TECHNOLOGY ANALYSIS             97

5.3.1        KEY TECHNOLOGIES     97

5.3.1.1    Real-time PCR/Quantitative PCR (qPCR) and digital PCR (dPCR)  97

5.3.1.2    Next-generation/Metagenomic sequencing (NGS/mNGS)                 98

5.3.1.3    CRISPR-based diagnostics 99

5.3.2        ADJACENT TECHNOLOGIES       99

5.3.2.1    Integrated LIMS and one health surveillance platforms 99

5.3.2.2    AI-driven diagnostic tools   100

5.3.3        COMPLEMENTARY TECHNOLOGIES       100

5.3.3.1    Telepathology       100

5.3.3.2    Breath and saliva-based diagnostic tools          101

5.4           PORTER’S FIVE FORCES ANALYSIS           102

5.4.1        THREAT OF NEW ENTRANTS      103

5.4.2        THREAT OF SUBSTITUTES          103

5.4.3        BARGAINING POWER OF SUPPLIERS       103

5.4.4        BARGAINING POWER OF BUYERS             104

5.4.5        INTENSITY OF COMPETITIVE RIVALRY 104

5.5           KEY STAKEHOLDERS & BUYING CRITERIA            105

5.5.1        KEY STAKEHOLDERS IN BUYING PROCESS           105

5.5.2        KEY BUYING CRITERIA  106

5.6           REGULATORY ANALYSIS               107

5.6.1        REGULATORY LANDSCAPE         107

5.6.1.1    North America      107

5.6.1.1.1 US           107

5.6.1.2    Europe   108

5.6.2        REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             108

5.7           PATENT ANALYSIS          111

5.7.1        PATENT PUBLICATION TRENDS FOR VETERINARY REFERENCE LABORATORY          111

5.7.2        JURISDICTION & TOP APPLICANT ANALYSIS      112

5.7.3        MAJOR PATENTS              113

5.8           PRICING ANALYSIS          115

5.8.1        AVERAGE SELLING PRICE TREND OF VETERINARY REFERENCE LABORATORY SERVICES, BY KEY PLAYER, 2022−2024            115

5.8.2        AVERAGE SELLING PRICE TREND OF CLINICAL CHEMISTRY AND IMMUNODIAGNOSTIC SERVICES, BY REGION, 2022–2024              117

5.9           REIMBURSEMENT ANALYSIS      119

5.10         PET PARENT BEHAVIOUR            120

5.11         KEY CONFERENCES & EVENTS, 2025–2026              122

5.12         END-USER PERSPECTIVE & UNMET NEEDS          123

5.13         IMPACT OF AI/GEN AI ON VETERINARY REFERENCE LABORATORY MARKET 124

5.13.1      INTRODUCTION              124

5.13.2      MARKET POTENTIAL IN VETERINARY REFERENCE LABORATORY ECOSYSTEM         124

5.13.3      AI-USE CASES    125

5.13.4      KEY COMPANIES IMPLEMENTING AI      125

5.14         ECOSYSTEM MAP             126

5.15         ROLE IN ECOSYSTEM     127

5.16         VALUE CHAIN ANALYSIS               128

5.17         INVESTMENT & FUNDING SCENARIO     130

5.18         CASE STUDY ANALYSIS 131

5.18.1      DIGITAL CYTOLOGY WORKFLOW ACCELERATION TO ENHANCE DIAGNOSTIC TURNAROUND IN VETERINARY PRACTICES         131

5.18.2      IDEXX-CANCERDX (LYMPHOMA DIAGNOSTIC SERVICE) TO ADVANCE ONCOLOGY DETECTION THROUGH BLOOD-BASED TESTING               132

5.18.3      VIRTUAL LABORATORY INTEGRATION TO ENHANCE CYTOLOGY TURNAROUND AND CLINICAL WORKFLOW                 133

5.19         TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS            134

5.20         IMPACT OF 2025 US TARIFF ON VETERINARY REFERENCE LABORATORY MARKET       134

5.20.1      INTRODUCTION              134

5.20.2      KEY TARIFF RATES          136

5.20.3      PRICE IMPACT ANALYSIS             137

5.20.4      IMPACT ON COUNTRY/REGION                138

5.20.4.1  North America      138

5.20.4.2  Europe   138

5.20.4.3  Asia Pacific            139

5.20.4.4  Latin America       139

5.20.5      IMPACT ON END-USE INDUSTRIES          139

5.20.5.1  Veterinary hospitals & clinics             139

5.20.5.2  Point-of-care (POC) and in-house testing setups          140

5.20.5.3  Veterinary research institutes & universities   140

5.20.5.4  Other end users    140

6               VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE               141

6.1           INTRODUCTION              142

6.2           CLINICAL CHEMISTRY   143

6.2.1        VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE              145

6.2.1.1    Companion animals              145

6.2.1.1.1 Rising pet ownership and preventive health trends to drive segment growth    145

6.2.1.2    Livestock animals 147

6.2.1.2.1 Rising focus on herd health, food safety, and export compliance to strengthen segment growth            147

6.3           IMMUNODIAGNOSTICS                149

6.3.1        VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE      152

6.3.1.1    ELISA    152

6.3.1.1.1 ELISA tests to dominate immunodiagnostics segment owing to widespread use in infectious disease detection                 152

6.3.2        LATERAL FLOW ASSAYS                154

6.3.2.1    Technological advancements and cost-effectiveness to aid market growth    154

6.3.3        ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS                 156

6.3.3.1    Rising prevalence of atopic disorders and adoption of precision allergy testing to augment market growth        156

6.3.4        OTHER IMMUNODIAGNOSTIC SERVICES              158

6.3.5        VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE           160

6.3.5.1    Companion animals              160

6.3.5.1.1 High pet care spending and preventive diagnostics to propel market growth       160

6.3.5.2    Livestock animals 162

6.3.5.2.1 Regulatory compliance, food safety, and disease surveillance to sustain steady demand         162

6.4           MOLECULAR DIAGNOSTICS       164

6.4.1        VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE              167

6.4.2        PCR TESTS          167

6.4.2.1    High sensitivity and diagnostic accuracy to drive dominance of PCR tests               167

6.4.3        MICROARRAYS  169

6.4.3.1    Advancements in genetic profiling and pharmacogenomics to expand microarray applications          169

6.4.4        NUCLEIC ACID SEQUENCING    171

6.4.4.1    Rising adoption of next-generation sequencing and precision genomics to fuel market growth         171

6.4.5        OTHER MOLECULAR DIAGNOSTIC SERVICES     173

6.4.6        VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE  175

6.4.6.1    Companion animals              175

6.4.6.1.1 High pet-owner spending, precision diagnostics, and rapid turnaround to drive dominance          175

6.4.6.2    Livestock animals 177

6.4.6.2.1 Regulatory mandates, disease surveillance, and one health initiatives to strengthen market presence         177

6.5           HEMATOLOGY 179

6.5.1        VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,

BY ANIMAL TYPE              181

6.5.1.1    Companion animals              181

6.5.1.1.1 High diagnostic frequency and technological advancements TO sustain segment growth       181

6.5.1.2    Livestock animals 183

6.5.1.2.1 Rising focus on herd health, biosecurity, and productivity optimization to drive steady market growth     183

6.6           URINALYSIS        185

6.6.1        VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS,

BY ANIMAL TYPE              187

6.6.1.1    Companion animals              187

6.6.1.1.1 Rising incidences of renal diseases in companion animals to drive market    187

6.6.1.2    Livestock animals 189

6.6.1.2.1 Growing emphasis on metabolic profiling and precision herd management to strengthen livestock urinalysis segment                189

6.7           HISTOPATHOLOGY & CYTOLOGY            191

6.7.1        VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE      193

6.7.1.1    Companion animals              193

6.7.1.1.1 Clinical reliance on laboratory-based tissue and cellular diagnostics for definitive case management to drive market         193

6.7.1.2    Livestock animals 195

6.7.1.2.1 Biosecurity investments and disease surveillance programs to drive steady demand            195

6.8           MICROBIOLOGY               197

6.8.1        VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,

BY ANIMAL TYPE              199

6.8.1.1    Companion animals              199

6.8.1.1.1 Rising AMR awareness and shift toward rapid and automated testing to spur market growth             199

6.8.1.2    Livestock animals 201

6.8.1.2.1 Antimicrobial resistance monitoring and food safety compliance to sustain demand                 201

6.9           OTHER SERVICES             203

6.9.1        VETERINARY REFERENCE LABORATORY MARKET FOR OTHER SERVICES,

BY ANIMAL TYPE              205

6.9.1.1    Companion animals              205

6.9.1.2    Livestock animals 207

7               VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION   209

7.1           INTRODUCTION              210

7.2           CLINICAL PATHOLOGY 210

7.2.1        INCREASING AWARENESS OF ANIMAL HEALTH TO DRIVE MARKET 210

7.3           BACTERIOLOGY               213

7.3.1        GROWTH IN VETERINARY HEALTHCARE EXPENDITURE TO DRIVE MARKET         213

7.4           VIROLOGY          215

7.4.1        EMERGING INFECTIOUS DISEASES IN ANIMALS TO PROPEL MARKET GROWTH         215

7.5           PARASITOLOGY                217

7.5.1        RISING PREVALENCE OF ZOONOTIC DISEASES TO AUGMENT MARKET GROWTH   217

7.6           PRODUCTIVITY TESTING            219

7.6.1        EXPANSION OF LIVESTOCK INDUSTRIES TO SUPPORT MARKET GROWTH          219

7.7           PREGNANCY TESTING  221

7.7.1        ADVANCED BREEDING TECHNIQUES AND RESPONSIBLE PET

OWNERSHIP TO DRIVE MARKET GROWTH          221

7.8           TOXICOLOGY TESTING                 223

7.8.1        GLOBALIZATION OF FOOD SUPPLY CHAINS TO PROPEL MARKET GROWTH          223

7.9           OTHER APPLICATIONS 225

8               VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE    227

8.1           INTRODUCTION              228

8.2           COMPANION ANIMALS 228

8.2.1        DOGS    232

8.2.1.1    High insurance coverage and availability of reimbursements

to drive market      232

8.2.2        CATS     234

8.2.2.1    Increasing pet cat population to support market uptake                 234

8.2.3        HORSES                236

8.2.3.1    Growing awareness regarding equine health to fuel market growth    236

8.2.4        OTHER COMPANION ANIMALS 239

8.3           LIVESTOCK ANIMALS    240

8.3.1        CATTLE                244

8.3.1.1    Growing consumption of dairy products to drive market growth                 244

8.3.2        SWINE  246

8.3.2.1    Increasing incidence of infectious diseases to fuel market growth                 246

8.3.3        POULTRY             248

8.3.3.1    Increasing demand for poultry meat to spur market growth                 248

8.3.4        SHEEP & GOATS                250

8.3.4.1    International trade and strict health regulations to drive market                 250

8.3.5        OTHER LIVESTOCK ANIMALS    252

9               VETERINARY REFERENCE LABORATORY MARKET, BY END USER            254

9.1           INTRODUCTION              255

9.2           VETERINARY HOSPITALS & CLINICS       255

9.2.1        RISING PET OWNERSHIP AND GROWING DIAGNOSTIC AWARENESS TO DRIVE DEMAND FOR VETERINARY REFERENCE LABS      255

9.3           POINT-OF-CARE/IN-HOUSE TESTING    258

9.3.1        INCREASING COLLABORATIONS BETWEEN IN-HOUSE DIAGNOSTIC SETUPS AND REFERENCE LABORATORIES TO AID MARKET GROWTH          258

9.4           VETERINARY RESEARCH INSTITUTES & UNIVERSITIES                 260

9.4.1        INCREASING ACADEMIC COLLABORATIONS AND FUNDING TO DRIVE UTILIZATION OF REFERENCE LABORATORY SERVICES               260

9.5           OTHER END USERS         262

10            VETERINARY REFERENCE LABORATORY MARKET, BY REGION                264

10.1         INTRODUCTION              265

10.2         NORTH AMERICA             266

10.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 266

10.2.2      US           274

10.2.2.1  US to dominate Norths American veterinary reference laboratory market during forecast period             274

10.2.3      CANADA               281

10.2.3.1  Growing pet adoption, rising animal healthcare expenditure, and increasing number of veterinary practices to drive market            281

10.3         EUROPE               288

10.3.1      MACROECONOMIC OUTLOOK FOR EUROPE      289

10.3.2      GERMANY           296

10.3.2.1  Increasing pet healthcare expenditure and rising demand for animal-derived food products to aid market growth       296

10.3.3      UK          303

10.3.3.1  Increased pet ownership and availability of animal health insurance policies to augment market growth 303

10.3.4      FRANCE                310

10.3.4.1  Growth of livestock industry and high companion animal population to support market growth                310

10.3.5      ITALY    317

10.3.5.1  Rising awareness about pet healthcare to drive market  317

10.3.6      SPAIN    324

10.3.6.1  Growing demand for pig and poultry products to drive market                 324

10.3.7      NETHERLANDS 331

10.3.7.1  Increasing animal healthcare expenditure to drive market growth                 331

10.3.8      REST OF EUROPE             338

10.4         ASIA PACIFIC     345

10.4.1      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 345

10.4.2      CHINA  353

10.4.2.1  Large pool of food-producing animals to drive market  353

10.4.3      JAPAN   360

10.4.3.1  Awareness about zoonotic diseases and increased pet expenditure to propel market growth      360

10.4.4      INDIA    368

10.4.4.1  Growing demand for livestock products and increasing awareness about animal health to support market growth                368

10.4.5      AUSTRALIA         376

10.4.5.1  Increasing investments in pet services and products to aid market growth    376

10.4.6      SOUTH KOREA  383

10.4.6.1  Increasing pet population in urban households to drive market                 383

10.4.7      THAILAND          390

10.4.7.1  Rapidly expanding companion animal population to create higher demand for advanced diagnostic testing           390

10.4.8      NEW ZEALAND 397

10.4.8.1  Increased demand for preventive care and high aging pet population to drive market growth    397

10.4.9      REST OF ASIA PACIFIC   404

10.5         LATIN AMERICA                411

10.5.1      MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 412

10.5.2      BRAZIL 419

10.5.2.1  Increasing use of reproductive technologies in livestock industry to propel market growth      419

10.5.3      MEXICO                426

10.5.3.1  Increasing adoption of advanced diagnostic technologies to propel market growth           426

10.5.4      ARGENTINA       433

10.5.4.1  Focus on advanced healthcare and regular disease monitoring among companion animals to drive market      433

10.5.5      REST OF LATIN AMERICA             440

10.6         MIDDLE EAST & AFRICA                447

10.6.1      MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 448

10.6.2      GCC COUNTRIES              455

10.6.2.1  Kingdom of Saudi Arabia    462

10.6.2.1.1                Technology advancements in veterinary diagnostics to boost market growth             462

10.6.2.2  UAE        469

10.6.2.2.1                Government support and favorable initiatives to fuel market growth       469

10.6.2.3  Rest of GCC Countries        476

10.6.3      REST OF MIDDLE EAST & AFRICA             482

11            COMPETITIVE LANDSCAPE         490

11.1         INTRODUCTION              490

11.2         KEY PLAYER STRATEGIES/RIGHT TO WIN            490

11.2.1      OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN VETERINARY REFERENCE LABORATORY MARKET                 490

11.3         REVENUE ANALYSIS, 2020−2024                 493

11.4         MARKET SHARE ANALYSIS, 2024                 494

11.4.1      RANKING OF KEY MARKET PLAYERS       494

11.4.2      GLOBAL MARKET SHARE ANALYSIS        495

11.4.3      US MARKET SHARE ANALYSIS    497

11.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 498

11.5.1      STARS   498

11.5.2      EMERGING LEADERS     498

11.5.3      PERVASIVE PLAYERS      498

11.5.4      PARTICIPANTS 498

11.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         500

11.5.5.1  Company footprint               500

11.5.5.2  Region footprint   501

11.5.5.3  Service footprint   502

11.5.5.4  Animal type footprint           503

11.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        504

11.6.1      PROGRESSIVE COMPANIES         504

11.6.2      RESPONSIVE COMPANIES            504

11.6.3      DYNAMIC COMPANIES  504

11.6.4      STARTING BLOCKS         504

11.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SME PLAYERS, 2024   506

11.6.5.1  Detailed list of key startups/SME players         506

11.6.5.2  Competitive benchmarking of key emerging players/startups                 507

11.7         BRAND/PRODUCT COMPARISON             508

11.8         R&D EXPENDITURE OF KEY PLAYERS     509

11.9         COMPANY VALUATION & FINANCIAL METRICS 509

11.9.1      FINANCIAL METRICS      509

11.9.2      COMPANY VALUATION 510

11.10       COMPETITIVE SCENARIO             510

11.10.1   SERVICE LAUNCHES & ENHANCEMENTS               510

11.10.2   DEALS  512

11.10.3   EXPANSIONS     513

11.10.4   OTHER DEVELOPMENTS              514

12            COMPANY PROFILES      515

12.1         KEY PLAYERS     515

12.1.1      IDEXX LABORATORIES, INC.       515

12.1.1.1  Business overview 515

12.1.1.2  Services offered     517

12.1.1.3  Recent developments           520

12.1.1.3.1                Service launches and enhancements 520

12.1.1.4  MnM view              521

12.1.1.4.1                Key strengths        521

12.1.1.4.2                Strategic choices   522

12.1.1.4.3                Weaknesses & competitive threats     522

12.1.2      MARS, INCORPORATED 523

12.1.2.1  Business overview 523

12.1.2.2  Services offered     524

12.1.2.3  Recent developments           526

12.1.2.3.1                Service launches   526

12.1.2.3.2                Deals      526

12.1.2.3.3                Expansions             527

12.1.2.4  MnM view              527

12.1.2.4.1                Key strengths        527

12.1.2.4.2                Strategic choices   527

12.1.2.4.3                Weaknesses & competitive threats     528

12.1.3      ZOETIS SERVICES LLC    529

12.1.3.1  Business overview 529

12.1.3.2  Services offered     531

12.1.3.3  Recent developments           533

12.1.3.3.1                Deals      533

12.1.3.3.2                Expansions             534

12.1.3.4  MnM view              534

12.1.3.4.1                Key strengths        534

12.1.3.4.2                Strategic choices   535

12.1.3.4.3                Weaknesses & competitive threats     535

12.1.4      GD (ROYAL GD ANIMAL HEALTH)            536

12.1.4.1  Business overview 536

12.1.4.2  Services offered     537

12.1.4.3  Recent developments           543

12.1.4.3.1                Service launches   543

12.1.4.3.2                Deals      544

12.1.4.3.3                Expansions             545

12.1.4.4  MnM view              545

12.1.4.4.1                Key strengths        545

12.1.4.4.2                Strategic choices   546

12.1.4.4.3                Weaknesses & competitive threats     546

12.1.5      LABOKLIN GMBH & CO. KG         547

12.1.5.1  Business overview 547

12.1.5.2  Services offered     547

12.1.5.3  Recent developments           549

12.1.5.3.1                Service launches   549

12.1.5.4  MnM view              550

12.1.5.4.1                Key strengths        550

12.1.5.4.2                Strategic choices   550

12.1.5.4.3                Weaknesses & competitive threats     550

12.1.6      CVS (UK) LIMITED           551

12.1.6.1  Business overview 551

12.1.6.2  Services offered     553

12.1.6.3  Recent developments           556

12.1.6.3.1                Service launches   556

12.1.7      NATIONAL VETERINARY SERVICES LABORATORY USDA-APHIS      557

12.1.7.1  Business overview 557

12.1.7.2  Services offered     557

12.1.8      ANIMAL AND PLANT HEALTH AGENCY 559

12.1.8.1  Business overview 559

12.1.8.2  Services offered     559

12.1.8.3  Recent developments           561

12.1.8.3.1                Other developments             561

12.1.9      ICAR–NIVEDI (NATIONAL INSTITUTE OF VETERINARY EPIDEMIOLOGY AND DISEASE INFORMATICS)  562

12.1.9.1  Business overview 562

12.1.9.2  Services offered     562

12.1.10   NATIONAL VETERINARY SERVICES          564

12.1.10.1                 Business overview 564

12.1.10.2                 Services offered     565

12.1.10.3                 Recent developments           566

12.1.10.3.1             Expansions             566

12.1.10.3.2             Other developments             567

12.1.11   TEXAS A&M VETERINARY MEDICAL DIAGNOSTIC LABORATORY (TVMDL)                568

12.1.11.1                 Business overview 568

12.1.11.2                 Services offered     568

12.1.11.3                 Recent developments           569

12.1.11.3.1             Service launches and enhancements 569

12.1.12   ANIMAL HEALTH DIAGNOSTIC CENTER, CORNELL UNIVERSITY       571

12.1.12.1                 Business overview 571

12.1.12.2                 Services offered     571

12.1.12.3                 Recent developments           573

12.1.12.3.1             Service launches   573

12.1.12.3.2             Expansions             574

12.1.13   COLORADO STATE UNIVERSITY (VETERINARY DIAGNOSTIC LABORATORY)      575

12.1.13.1                 Business overview 575

12.1.13.2                 Services offered     575

12.1.14   BIOBEST LABORATORIES LTD.  578

12.1.14.1                 Business overview 578

12.1.14.2                 Services offered     579

12.1.14.3                 Recent developments           581

12.1.14.3.1             Expansions             581

12.1.15   PRIVATE VETERINARY CLINIC SAN MARCO SRL UNIPERSONALE                582

12.1.15.1                 Business overview 582

12.1.15.2                 Services offered     582

12.2         OTHER PLAYERS              584

12.2.1      ROYAL VETERINARY COLLEGE, UNIVERSITY OF LONDON             584

12.2.2      UNIVERSITY OF GUELPH, ANIMAL HEALTH LABORATORY   585

12.2.3      VAXXINOVA       586

12.2.4      MIRA VISTA LABS             588

12.2.5      ELLIE DIAGNOSTICS      589

12.2.6      PROTATEK INTERNATIONAL, INC.          590

12.2.7      THE PIRBRIGHT INSTITUTE       591

12.2.8      CVR LABORATORY (CVRL)           592

12.2.9      VETERINARY PATHOLOGY GROUP          593

12.2.10   FRIEDRICH-LOEFFLER-INSTITUT (FLI)  594

13            APPENDIX           595

13.1         DISCUSSION GUIDE        595

13.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                601

13.3         CUSTOMIZATION OPTIONS        603

13.3.1      SERVICE ANALYSIS          603

13.3.2      COMPANY INFORMATION           603

13.3.3      GEOGRAPHIC ANALYSIS               603

13.3.4      REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS            603

13.3.5      COUNTRY-LEVEL VOLUME ANALYSIS BY PRODUCT                 603

13.3.6      BY SERVICE MARKET SHARE ANALYSIS (TOP 5 PLAYERS)                 603

13.3.7      ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS          603

13.4         RELATED REPORTS         604

13.5         AUTHOR DETAILS           605

LIST OF TABLES

TABLE 1                VETERINARY REFERENCE LABORATORY MARKET: INCLUSIONS & EXCLUSIONS   50

TABLE 2                STANDARD CURRENCY CONVERSION RATES (UNIT OF USD) 51

TABLE 3                VETERINARY REFERENCE LABORATORY MARKET: MARKET ASSUMPTIONS           70

TABLE 4                VETERINARY REFERENCE LABORATORY MARKET: RISK ANALYSIS              71

TABLE 5                ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES, 2009–2023   86

TABLE 6                NUMBER OF US HOUSEHOLDS THAT OWN A PET IN 2024,

BY ANIMAL TYPE (MILLIONS)    88

TABLE 7                US: AVERAGE PREMIUMS PAID, 2020 VS. 2023                 90

TABLE 8                NORTH AMERICA: PET HEALTH INSURANCE MARKET, 2012–2023 (USD MILLION)        91

TABLE 9                VETERINARY REFERENCE LABORATORY MARKET: PORTER’S FIVE FORCES             102

TABLE 10              INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY REFERENCE LABORATORY PRODUCTS (%) 105

TABLE 11              KEY BUYING CRITERIA FOR TOP THREE END USERS   107

TABLE 12              NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  108

TABLE 13              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS           110

TABLE 14              REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 111

TABLE 15              MAJOR PATENTS IN VETERINARY REFERENCE LABORATORY MARKET 113

TABLE 16              AVERAGE SELLING PRICE TREND OF VETERINARY REFERENCE LABORATORY SERVICES, BY KEY PLAYER, 2022–2024 (USD)              115

TABLE 17              AVERAGE SELLING PRICE TREND OF CLINICAL CHEMISTRY SERVICES, BY REGION, 2022–2024 (USD)       117

TABLE 18              AVERAGE SELLING PRICE TREND OF IMMUNODIAGNOSTIC SERVICES, BY REGION, 2022–2024 (USD)                 118

TABLE 19              AVERAGE SELLING PRICE TREND OF MOLECULAR DIAGNOSTIC SERVICES,

BY REGION, 2022–2024 (USD)      118

TABLE 20              AVERAGE SELLING PRICE TREND OF HAEMATOLOGY SERVICES, BY REGION, 2022–2024 (USD)                 118

TABLE 21              AVERAGE SELLING PRICE TREND OF HISTOPATHOLOGY &CYTOLOGY SERVICES,

BY REGION, 2022–2024 (USD)      119

TABLE 22              AVERAGE SELLING PRICE TREND OF URINALYSIS SERVICES, BY REGION,

2022–2024 (USD)                119

TABLE 23              KEY CONFERENCES & EVENTS IN VETERINARY REFERENCE LABORATORY MARKET, JANUARY 2025–DECEMBER 2026        122

TABLE 24              KEY COMPANIES IMPLEMENTING AI IN VETERINARY REFERENCE

LABORATORY MARKET 126

TABLE 25              VETERINARY REFERENCE LABORATORY PROVIDERS: ROLE IN ECOSYSTEM           127

TABLE 26              CASE STUDY 1: DIGITAL CYTOLOGY WORKFLOW ACCELERATION TO ENHANCE DIAGNOSTIC TURNAROUND IN VETERINARY PRACTICES        131

TABLE 27              CASE STUDY 2: IDEXX-CANCERDX (LYMPHOMA DIAGNOSTIC SERVICE) TO ADVANCE ONCOLOGY DETECTION THROUGH BLOOD-BASED TESTING       132

TABLE 28              CASE STUDY 3: VIRTUAL LABORATORY INTEGRATION TO ENHANCE CYTOLOGY TURNAROUND AND CLINICAL WORKFLOW  133

TABLE 29              US-ADJUSTED RECIPROCAL TARIFF RATES                 136

TABLE 30              KEY PRODUCT-RELATED TARIFF EFFECTIVE VETERINARY REFERENCE LABORATORY               136

TABLE 31              IMPACT OF US TARIFF ON CANADA        138

TABLE 32              IMPACT OF US TARIFF ON GERMANY AND UK                 138

TABLE 33              IMPACT OF US TARIFF ON CHINA, JAPAN, AND INDIA    139

TABLE 34              IMPACT OF US TARIFF ON MEXICO         139

TABLE 35              VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,

2023–2030 (USD MILLION)            142

TABLE 36              KEY PLAYERS PROVIDING CLINICAL CHEMISTRY SERVICES   143

TABLE 37              VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY,

BY COUNTRY, 2023–2030 (USD MILLION)               144

TABLE 38              VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       145

TABLE 39              CLINICAL CHEMISTRY MARKET FOR COMPANION ANIMALS, BY COUNTRY,

2023–2030 (USD MILLION)            146

TABLE 40              CLINICAL CHEMISTRY MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY,

2023–2030 (USD MILLION)          148

TABLE 41              KEY PLAYERS PROVIDING IMMUNODIAGNOSTIC TECHNOLOGIES                150

TABLE 42              VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS,

BY COUNTRY, 2023–2030 (USD MILLION)               151

TABLE 43              VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS,

BY SERVICE, 2023–2030 (USD MILLION)  152

TABLE 44              IMMUNODIAGNOSTICS MARKET FOR ELISA, BY COUNTRY,

2023–2030 (USD MILLION)            153

TABLE 45              IMMUNODIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS,

BY COUNTRY, 2023–2030 (USD MILLION)               155

TABLE 46              IMMUNODIAGNOSTICS MARKET FOR ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS, BY COUNTRY, 2023–2030 (USD MILLION)     157

TABLE 47              OTHER IMMUNODIAGNOSTICS SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            159

TABLE 48              VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS,

BY ANIMAL TYPE , 2023–2030 (USD MILLION)      160

TABLE 49              IMMUNODIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY COUNTRY,

2023–2030 (USD MILLION)            161

TABLE 50              IMMUNODIAGNOSTICS MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY,

2023–2030 (USD MILLION)            163

TABLE 51              KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTIC SERVICES 165

TABLE 52              VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)       166

TABLE 53              VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)       167

TABLE 54              MOLECULAR DIAGNOSTICS MARKET FOR PCR TESTS, BY COUNTRY,

2023–2030 (USD MILLION)            168

TABLE 55              MOLECULAR DIAGNOSTICS MARKET FOR MICROARRAYS, BY COUNTRY,

2023–2030 (USD MILLION)            170

TABLE 56              MOLECULAR DIAGNOSTICS MARKET FOR NUCLEIC ACID SEQUENCING,

BY COUNTRY, 2023–2030 (USD MILLION)               172

TABLE 57              OTHER MOLECULAR DIAGNOSTIC SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            174

TABLE 58              VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            175

TABLE 59              MOLECULAR DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)                 176

TABLE 60              MOLECULAR DIAGNOSTICS MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)                 178

TABLE 61              KEY PLAYERS PROVIDING HAEMATOLOGY SERVICES             179

TABLE 62              VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)            180

TABLE 63              VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            181

TABLE 64              HAEMATOLOGY MARKET FOR COMPANION ANIMALS, BY COUNTRY,

2023–2030 (USD MILLION)            182

TABLE 65              HAEMATOLOGY MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY,

2023–2030 (USD MILLION)            184

TABLE 66              KEY PLAYERS PROVIDING URINALYSIS TECHNOLOGIES               185

TABLE 67              VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY COUNTRY, 2023–2030 (USD MILLION)            186

TABLE 68              VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            187

TABLE 69              URINALYSIS MARKET FOR COMPANION ANIMALS, BY COUNTRY,

2023–2030 (USD MILLION)            188

TABLE 70             URINALYSIS MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY,

2023–2030 (USD MILLION)            190

TABLE 71              KEY PLAYERS PROVIDING HISTOPATHOLOGY & CYTOLOGY SERVICES    191

TABLE 72              VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)            192

TABLE 73              VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                193

TABLE 74              HISTOPATHOLOGY & CYTOLOGY MARKET FOR COMPANION ANIMALS,

BY COUNTRY, 2023–2030 (USD MILLION)               194

TABLE 75              HISTOPATHOLOGY & CYTOLOGY MARKET FOR LIVESTOCK ANIMALS,

BY COUNTRY, 2023–2030 (USD MILLION)               196

TABLE 76              KEY PLAYERS PROVIDING MICROBIOLOGY SERVICES             197

TABLE 77              VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,

BY COUNTRY, 2023–2030 (USD MILLION)               198

TABLE 78              VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 199

TABLE 79              MICROBIOLOGY MARKET FOR COMPANION ANIMALS, BY COUNTRY,

2023–2030 (USD MILLION)            200

TABLE 80              MICROBIOLOGY MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY,

2023–2030 (USD MILLION)            202

TABLE 81              KEY PLAYERS PROVIDING OTHER VETERINARY REFERENCE

LABORATORY SERVICES               203

TABLE 82              VETERINARY REFERENCE LABORATORY MARKET FOR OTHER SERVICES,

BY COUNTRY, 2023–2030 (USD MILLION)               204

TABLE 83              VETERINARY REFERENCE LABORATORY MARKET FOR OTHER SERVICES,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       205

TABLE 84              OTHER VETERINARY REFERENCE LABORATORY SERVICES MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)            206

TABLE 85              OTHER VETERINARY REFERENCE LABORATORY SERVICES MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)            208

TABLE 86              VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            210

TABLE 87              KEY PLAYERS PROVIDING CLINICAL PATHOLOGY SERVICES 211

TABLE 88              VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL PATHOLOGY,

BY COUNTRY, 2023–2030 (USD MILLION)               212

TABLE 89              KEY PLAYERS PROVIDING BACTERIOLOGY SERVICES             213

TABLE 90              VETERINARY REFERENCE LABORATORY MARKET FOR BACTERIOLOGY,

BY COUNTRY, 2023–2030 (USD MILLION)               214

TABLE 91              KEY PLAYERS PROVIDING VIROLOGY SERVICES                 215

TABLE 92              VETERINARY REFERENCE LABORATORY MARKET FOR VIROLOGY, BY COUNTRY, 2023–2030 (USD MILLION)            216

TABLE 93              KEY PLAYERS PROVIDING PARASITOLOGY SERVICES             217

TABLE 94              VETERINARY REFERENCE LABORATORY MARKET FOR PARASITOLOGY,

BY COUNTRY, 2023–2030 (USD MILLION)               218

TABLE 95              KEY PLAYERS PROVIDING PRODUCTIVITY TESTING SERVICES         219

TABLE 96              VETERINARY REFERENCE LABORATORY MARKET FOR PRODUCTIVITY TESTING,

BY COUNTRY, 2023–2030 (USD MILLION)               220

TABLE 97              KEY PLAYERS PROVIDING PREGNANCY TESTING SERVICES         221

TABLE 98              VETERINARY REFERENCE LABORATORY MARKET FOR PREGNANCY TESTING,

BY COUNTRY, 2023–2030 (USD MILLION)               222

TABLE 99              KEY PLAYERS PROVIDING TOXICOLOGY TESTING SERVICES         223

TABLE 100            VETERINARY REFERENCE LABORATORY MARKET FOR TOXICOLOGY TESTING,

BY COUNTRY, 2023–2030 (USD MILLION)               224

TABLE 101            VETERINARY REFERENCE LABORATORY MARKET FOR OTHER APPLICATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               226

TABLE 102            VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            228

TABLE 103            KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR COMPANION ANIMALS              229

TABLE 104            VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS,

BY TYPE, 2023–2030 (USD MILLION)         230

TABLE 105            VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS,

BY COUNTRY, 2023–2030 (USD MILLION)               231

TABLE 106            KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY

SERVICES FOR DOGS      232

TABLE 107            VETERINARY REFERENCE LABORATORY MARKET FOR DOGS, BY COUNTRY,

2023–2030 (USD MILLION)            233

TABLE 108            KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES

FOR CATS            234

TABLE 109            VETERINARY REFERENCE LABORATORY MARKET FOR CATS, BY COUNTRY,

2023–2030 (USD MILLION)            235

TABLE 110            KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY

SERVICES FOR HORSES 236

TABLE 111            VETERINARY REFERENCE LABORATORY MARKET FOR HORSES, BY COUNTRY, 2023–2030 (USD MILLION)                 238

TABLE 112            VETERINARY REFERENCE LABORATORY MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)            239

TABLE 113            KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR LIVESTOCK ANIMALS                 240

TABLE 114            VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS,

BY TYPE, 2023–2030 (USD MILLION)         242

TABLE 115            VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS,

BY COUNTRY, 2023–2030 (USD MILLION)               243

TABLE 116            KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES

FOR CATTLE      244

TABLE 117            VETERINARY REFERENCE LABORATORY MARKET FOR CATTLE, BY COUNTRY, 2023–2030 (USD MILLION)                 245

TABLE 118            KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES

FOR SWINE         246

TABLE 119            VETERINARY REFERENCE LABORATORY MARKET FOR SWINE, BY COUNTRY,

2023–2030 (USD MILLION)            247

TABLE 120            KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES

FOR POULTRY   248

TABLE 121            VETERINARY REFERENCE LABORATORY MARKET FOR POULTRY, BY COUNTRY, 2023–2030 (USD MILLION)            249

TABLE 122            VETERINARY REFERENCE LABORATORY MARKET FOR SHEEP & GOATS,

BY COUNTRY, 2023–2030 (USD MILLION)               251

TABLE 123            VETERINARY REFERENCE LABORATORY MARKET FOR OTHER LIVESTOCK ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)       253

TABLE 124            VETERINARY REFERENCE LABORATORY MARKET, BY END USER,

2023–2030 (USD MILLION)            255

TABLE 125            US: BASIC ANNUAL EXPENSES FOR CATS AND DOGS, 2023 (USD)            256

TABLE 126            VETERINARY REFERENCE LABORATORY MARKET FOR VETERINARY HOSPITALS & CLINICS BY COUNTRY, 2023–2030 (USD MILLION)            257

TABLE 127            VETERINARY REFERENCE LABORATORY MARKET FOR POINT-OF-CARE/IN-HOUSE TESTING BY COUNTRY, 2023–2030 (USD MILLION)     259

TABLE 128            VETERINARY REFERENCE LABORATORY MARKET FOR VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2023–2030 (USD MILLION)                 261

TABLE 129            VETERINARY REFERENCE LABORATORY MARKET FOR OTHER END USERS,

BY COUNTRY, 2023–2030 (USD MILLION)               263

TABLE 130            VETERINARY REFERENCE LABORATORY MARKET, BY REGION,

2023–2030 (USD MILLION)            266

TABLE 131            NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            268

TABLE 132            NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION)                 268

TABLE 133            NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                269

TABLE 134            NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              269

TABLE 135            NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              269

TABLE 136            NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            270

TABLE 137            NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            270

TABLE 138            NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       270

TABLE 139            NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            271

TABLE 140            NORTH AMERICA: OTHER VETERINARY REFERENCE LABORATORY MARKET,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       271

TABLE 141            NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)         271

TABLE 142            NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)         272

TABLE 143            NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET,

BY APPLICATION, 2023–2030 (USD MILLION)       272

TABLE 144            NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       273

TABLE 145            NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            273

TABLE 146            NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            273

TABLE 147            NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET,

BY END USER, 2023–2030 (USD MILLION)               274

TABLE 148            US: KEY MACROINDICATORS     275

TABLE 149            US: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,

2023–2030 (USD MILLION)            275

TABLE 150            US: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       276

TABLE 151            US: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       276

TABLE 152            US: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            276

TABLE 153            US: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       277

TABLE 154            US: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            277

TABLE 155            US: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                277

TABLE 156            US: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       278

TABLE 157            US: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            278

TABLE 158            US: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 278

TABLE 159            US: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)       279

TABLE 160            US: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            279

TABLE 161            US: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            280

TABLE 162            US: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            280

TABLE 163            US: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS,

BY TYPE, 2023–2030 (USD MILLION)         280

TABLE 164            US: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,

2023–2030 (USD MILLION)            281

TABLE 165            CANADA: KEY MACROINDICATORS         282

TABLE 166            CANADA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,

2023–2030 (USD MILLION)            282

TABLE 167            CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                283

TABLE 168            CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              283

TABLE 169            CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              283

TABLE 170            CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       284

TABLE 171            CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       284

TABLE 172            CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       284

TABLE 173            CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       285

TABLE 174            CANADA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            285

TABLE 175            CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)         285

TABLE 176            CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)         286

TABLE 177            CANADA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            286

TABLE 178            CANADA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            287

TABLE 179            CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            287

TABLE 180            CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            287

TABLE 181            CANADA: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,

2023–2030 (USD MILLION)            288

TABLE 182            EUROPE: COMPANION POPULATION, BY COUNTRY, 2023 (MILLION)          289

TABLE 183            EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            290

TABLE 184            EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,

2023–2030 (USD MILLION)            290

TABLE 185            EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                291

TABLE 186            EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              291

TABLE 187            EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              291

TABLE 188            EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       292

TABLE 189            EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       292

TABLE 190            EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       292

TABLE 191            EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       293

TABLE 192            EUROPE: OTHER VETERINARY REFERENCE LABORATORY MARKET,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       293

TABLE 193            EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)         293

TABLE 194            EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)         294

TABLE 195            EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            294

TABLE 196            EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            295

TABLE 197            EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            295

TABLE 198            EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            295

TABLE 199            EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,

2023–2030 (USD MILLION)            296

TABLE 200            GERMANY: KEY MACROINDICATORS      297

TABLE 201            GERMANY: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,

2023–2030 (USD MILLION)            297

TABLE 202            GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                297

TABLE 203            GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              298

TABLE 204            GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              298

TABLE 205            GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            298

TABLE 206            GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       299

TABLE 207            GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       299

TABLE 208            GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            299

TABLE 209            GERMANY: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            300

TABLE 210            GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)         300

TABLE 211            GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)         300

TABLE 212            GERMANY: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            301

TABLE 213            GERMANY: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            301

TABLE 214            GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            302

TABLE 215            GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            302

TABLE 216            GERMANY: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,

2023–2030 (USD MILLION)            303

TABLE 217            UK: KEY MACROINDICATORS     304

TABLE 218            UK: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,

2023–2030 (USD MILLION)            304

TABLE 219            UK: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       305

TABLE 220            UK: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       305

TABLE 221            UK: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            305

TABLE 222            UK: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       306

TABLE 223            UK: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            306

TABLE 224            UK: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                306

TABLE 225            UK: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       307

TABLE 226            UK: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            307

TABLE 227            UK: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 307

TABLE 228            UK: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)       308

TABLE 229            UK: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            308

TABLE 230            UK: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            309

TABLE 231            UK: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            309

TABLE 232            UK: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS,

BY TYPE, 2023–2030 (USD MILLION)         309

TABLE 233            UK: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,

2023–2030 (USD MILLION)            310

TABLE 234            FRANCE: KEY MACROINDICATORS          310

TABLE 235            FRANCE: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,

2023–2030 (USD MILLION)            311

TABLE 236            FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                311

TABLE 237            FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              312

TABLE 238            FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              312

TABLE 239            FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       312

TABLE 240            FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       313

TABLE 241            FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       313

TABLE 242            FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       313

TABLE 243            RANCE: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            314

TABLE 244            FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)         314

TABLE 245            FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)         314

TABLE 246            FRANCE: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            315

TABLE 247            FRANCE: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            315

TABLE 248            FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            316

TABLE 249            FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            316

TABLE 250            FRANCE: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,

2023–2030 (USD MILLION)            317

TABLE 251            ITALY: KEY MACROINDICATORS               317

TABLE 252            ITALY: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,

2023–2030 (USD MILLION)            318

TABLE 253            ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       318

TABLE 254            ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       319

TABLE 255            ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            319

TABLE 256            ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       319

TABLE 257            ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            320

TABLE 258            ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                320

TABLE 259            ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       320

TABLE 260            ITALY: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            321

TABLE 261            ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 321

TABLE 262            ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)       321

TABLE 263            ITALY: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            322

TABLE 264            ITALY: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            322

TABLE 265            ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            323

TABLE 266            ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            323

TABLE 267            ITALY: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,

2023–2030 (USD MILLION)            324

TABLE 268            SPAIN: KEY MACROINDICATORS               325

TABLE 269            SPAIN: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,

2023–2030 (USD MILLION)            325

TABLE 270            SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       326

TABLE 271            SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       326

TABLE 272            SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            326

TABLE 273            SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       327

TABLE 274            SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       327

TABLE 275            SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                327

TABLE 276            SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       328

TABLE 277            SPAIN: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            328

TABLE 278            SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 328

TABLE 279            SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)       329

TABLE 280            SPAIN: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            329

TABLE 281            SPAIN: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            330

TABLE 282            SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            330

TABLE 283            SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            330

TABLE 284            SPAIN: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,

2023–2030 (USD MILLION)            331

TABLE 285            NETHERLANDS: KEY MACROINDICATORS                 331

TABLE 286            NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION)                 332

TABLE 287            NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                332

TABLE 288            NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              333

TABLE 289            NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              333

TABLE 290            NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            333

TABLE 291            NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            334

TABLE 292            NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       334

TABLE 293            NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            334

TABLE 294            NETHERLANDS: OTHER VETERINARY REFERENCE LABORATORY MARKET,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       335

TABLE 295            NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)         335

TABLE 296            NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)         335

TABLE 297            NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            336

TABLE 298            NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            336

TABLE 299            NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            337

TABLE 300            NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            337

TABLE 301            NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION)            338

TABLE 302            REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION)                 339

TABLE 303            REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                339

TABLE 304            REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              340

TABLE 305            REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              340

TABLE 306            REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            340

TABLE 307            REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            341

TABLE 308            REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       341

TABLE 309            REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            341

TABLE 310            REST OF EUROPE: OTHER VETERINARY REFERENCE LABORATORY MARKET,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       342

TABLE 311            REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET

FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)            342

TABLE 312            REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET

FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)            342

TABLE 313            REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET,

BY APPLICATION, 2023–2030 (USD MILLION)       343

TABLE 314            REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            343

TABLE 315            REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET

FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)                 344

TABLE 316            REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET

FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)                 344

TABLE 317            REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET,

BY END USER, 2023–2030 (USD MILLION)               345

TABLE 318            ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            347

TABLE 319            ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION)                 347

TABLE 320            ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                348

TABLE 321            ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              348

TABLE 322            ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              348

TABLE 323            ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            349

TABLE 324            ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            349

TABLE 325            ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       349

TABLE 326            ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            350

TABLE 327            ASIA PACIFIC: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            350

TABLE 328            ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)         350

TABLE 329            ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)         351

TABLE 330            ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            351

TABLE 331            ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            352

TABLE 332            ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            352

TABLE 333            ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            352

TABLE 334            ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET,

BY END USER, 2023–2030 (USD MILLION)               353

TABLE 335            CHINA: KEY MACROINDICATORS             354

TABLE 336            CHINA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,

2023–2030 (USD MILLION)            354

TABLE 337            CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       355

TABLE 338            CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       355

TABLE 339            CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            355

TABLE 340            CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       356

TABLE 341            CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       356

TABLE 342            CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                356

TABLE 343            CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       357

TABLE 344            CHINA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            357

TABLE 345            CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 357

TABLE 346            CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)       358

TABLE 347            CHINA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            358

TABLE 348            CHINA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            359

TABLE 349            CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            359

TABLE 350            CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            359

TABLE 351            CHINA: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,

2023–2030 (USD MILLION)            360

TABLE 352            JAPAN: PRODUCTION, CONSUMPTION, IMPORT, AND EXPORT OF

ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS) 361

TABLE 353            JAPAN: KEY MACROINDICATORS              361

TABLE 354            JAPAN: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,

2023–2030 (USD MILLION)            362

TABLE 355            JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       362

TABLE 356            JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       363

TABLE 357            JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            363

TABLE 358            JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       363

TABLE 359            JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       364

TABLE 360            JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                364

TABLE 361            JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       364

TABLE 362            JAPAN: OTHER VETERINARY REFERENCE LABORATORY MARKET,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       365

TABLE 363            JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 365

TABLE 364            JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)       365

TABLE 365            JAPAN: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            366

TABLE 366            JAPAN: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            366

TABLE 367            JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            367

TABLE 368            JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            367

TABLE 369            JAPAN: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,

2023–2030 (USD MILLION)            368

TABLE 370            INDIA: PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS) 369

TABLE 371            INDIA: KEY MACROINDICATORS               369

TABLE 372            INDIA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,

2023–2030 (USD MILLION)            370

TABLE 373            INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       370

TABLE 374            INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       371

TABLE 375            INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            371

TABLE 376            INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       371

TABLE 377            INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       372

TABLE 378            INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                372

TABLE 379            INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       372

TABLE 380            INDIA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            373

TABLE 381            INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 373

TABLE 382            INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)       373

TABLE 383            INDIA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            374

TABLE 384            INDIA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            374

TABLE 385            INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            375

TABLE 386            INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            375

TABLE 387            INDIA: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,

2023–2030 (USD MILLION)            376

TABLE 388            AUSTRALIA: KEY MACROINDICATORS   377

TABLE 389            AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,

2023–2030 (USD MILLION)            377

TABLE 390            AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                378

TABLE 391            AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              378

TABLE 392            AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              378

TABLE 393            AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            379

TABLE 394            AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       379

TABLE 395            AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       379

TABLE 396            AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            380

TABLE 397            AUSTRALIA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            380

TABLE 398            AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)         380

TABLE 399            AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)         381

TABLE 400            AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            381

TABLE 401            AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            382

TABLE 402            AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            382

TABLE 403            AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            382

TABLE 404            AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION)            383

TABLE 405            SOUTH KOREA: KEY MACROINDICATORS                 383

TABLE 406            SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION)                 384

TABLE 407            SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                384

TABLE 408            SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              385

TABLE 409            SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              385

TABLE 410            SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            385

TABLE 411            SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            386

TABLE 412            SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       386

TABLE 413            SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            386

TABLE 414            SOUTH KOREA: OTHER VETERINARY REFERENCE LABORATORY MARKET,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       387

TABLE 415            SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)         387

TABLE 416            SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)         387

TABLE 417            SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            388

TABLE 418            SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            388

TABLE 419            SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            389

TABLE 420            SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            389

TABLE 421            SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION)            390

TABLE 422            THAILAND: KEY MACROINDICATORS    391

TABLE 423            THAILAND: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,

2023–2030 (USD MILLION)            391

TABLE 424            THAILAND: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                392

TABLE 425            THAILAND: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              392

TABLE 426            THAILAND: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              392

TABLE 427            THAILAND: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       393

TABLE 428            THAILAND: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       393

TABLE 429            THAILAND: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       393

TABLE 430            THAILAND: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            394

TABLE 431            THAILAND: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            394

TABLE 432            THAILAND: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)         394

TABLE 433            THAILAND: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)         395

TABLE 434            THAILAND: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            395

TABLE 435            THAILAND: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            396

TABLE 436            THAILAND: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            396

TABLE 437            THAILAND: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            396

TABLE 438            THAILAND: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,

2023–2030 (USD MILLION)            397

TABLE 439            NEW ZEALAND: KEY MACROINDICATORS                 398

TABLE 440            NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION)                 398

TABLE 441            NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                399

TABLE 442            NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              399

TABLE 443            NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              399

TABLE 444            NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            400

TABLE 445            NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            400

TABLE 446            NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       400

TABLE 447            NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            401

TABLE 448            NEW ZEALAND: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       401

TABLE 449            NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)         401

TABLE 450            NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)         402

TABLE 451            NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            402

TABLE 452            NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            403

TABLE 453            NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            403

TABLE 454            NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            403

TABLE 455            NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET,

BY END USER, 2023–2030 (USD MILLION)               404

TABLE 456            REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET,

BY SERVICE, 2023–2030 (USD MILLION)  405

TABLE 457            REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET

FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            405

TABLE 458            REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET

FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            406

TABLE 459            REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET

FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 406

TABLE 460            REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET

FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            406

TABLE 461            REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET

FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                 407

TABLE 462            REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                 407

TABLE 463            REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              407

TABLE 464            REST OF ASIA PACIFIC: OTHER VETERINARY REFERENCE LABORATORY MARKET,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       408

TABLE 465            REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET

FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)            408

TABLE 466            REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET

FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)            408

TABLE 467            REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET,

BY APPLICATION, 2023–2030 (USD MILLION)       409

TABLE 468            REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       409

TABLE 469            REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET

FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)                 410

TABLE 470            REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET

FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)                 410

TABLE 471            REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET,

BY END USER, 2023–2030 (USD MILLION)               411

TABLE 472            LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            412

TABLE 473            LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION)                 413

TABLE 474            LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                413

TABLE 475            LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              414

TABLE 476            LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              414

TABLE 477            LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET

FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            414

TABLE 478            LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET

FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                 415

TABLE 479            LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       415

TABLE 480            LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET

FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            415

TABLE 481            LATIN AMERICA: OTHER VETERINARY REFERENCE LABORATORY MARKET,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       416

TABLE 482            LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET

FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)            416

TABLE 483            LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET

FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)            416

TABLE 484            LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET,

BY APPLICATION, 2023–2030 (USD MILLION)       417

TABLE 485            LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            417

TABLE 486            LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET

FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)                 418

TABLE 487            LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            418

TABLE 488            LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET,

BY END USER, 2023–2030 (USD MILLION)               419

TABLE 489            BRAZIL: KEY MACROINDICATORS            420

TABLE 490            BRAZIL: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,

2023–2030 (USD MILLION)            420

TABLE 491            BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                420

TABLE 492            BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              421

TABLE 493            BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              421

TABLE 494            BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       421

TABLE 495            BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       422

TABLE 496            BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       422

TABLE 497            BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       422

TABLE 498            BRAZIL: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            423

TABLE 499            BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)         423

TABLE 500            BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)         423

TABLE 501            BRAZIL: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            424

TABLE 502            BRAZIL: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            424

TABLE 503            BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            425

TABLE 504            BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            425

TABLE 505            BRAZIL: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,

2023–2030 (USD MILLION)            426

TABLE 506            MEXICO: KEY MACROINDICATORS          427

TABLE 507            MEXICO: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,

2023–2030 (USD MILLION)            427

TABLE 508            MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                427

TABLE 509            MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              428

TABLE 510            MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              428

TABLE 511            MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       428

TABLE 512            MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       429

TABLE 513            MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       429

TABLE 514            MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       429

TABLE 515            MEXICO: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            430

TABLE 516            MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)         430

TABLE 517            MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)         430

TABLE 518            MEXICO: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            431

TABLE 519            MEXICO: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            431

TABLE 520            MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            432

TABLE 521            MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            432

TABLE 522            MEXICO: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,

2023–2030 (USD MILLION)            433

TABLE 523            ARGENTINA: KEY MACROINDICATORS 434

TABLE 524            ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,

2023–2030 (USD MILLION)            434

TABLE 525            ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                434

TABLE 526            ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              435

TABLE 527            ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              435

TABLE 528            ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            435

TABLE 529            ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       436

TABLE 530            ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       436

TABLE 531            ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            436

TABLE 532            ARGENTINA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            437

TABLE 533            ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)         437

TABLE 534            ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)         437

TABLE 535            ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            438

TABLE 536            ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            438

TABLE 537            ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            439

TABLE 538            ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            439

TABLE 539            ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION)            440

TABLE 540            REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET,

BY SERVICE, 2023–2030 (USD MILLION)  441

TABLE 541            REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET

FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            441

TABLE 542            REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET

FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            442

TABLE 543            REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET

FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 442

TABLE 544            REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET

FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            442

TABLE 545            REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET

FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                 443

TABLE 546            REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                 443

TABLE 547            REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              443

TABLE 548            REST OF LATIN AMERICA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       444

TABLE 549            REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET

FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)            444

TABLE 550            REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET

FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)            445

TABLE 551            REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET,

BY APPLICATION, 2023–2030 (USD MILLION)       445

TABLE 552            REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       446

TABLE 553            REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET

FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)                 446

TABLE 554            REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET

FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)                 446

TABLE 555            REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET,

BY END USER, 2023–2030 (USD MILLION)               447

TABLE 556            MIDDLE EAST & ARICA: VETERINARY REFERENCE LABORATORY MARKET,

BY REGION, 2023–2030 (USD MILLION)   448

TABLE 557            MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET,

BY SERVICE, 2023–2030 (USD MILLION)  449

TABLE 558            MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET

FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            449

TABLE 559            MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET

FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            450

TABLE 560            MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET

FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 450

TABLE 561            MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET

FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            450

TABLE 562            MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET

FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                 451

TABLE 563            MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                 451

TABLE 564            MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              451

TABLE 565            MIDDLE EAST & AFRICA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       452

TABLE 566            MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET

FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)            452

TABLE 567            MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET

FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)            452

TABLE 568            MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET,

BY APPLICATION, 2023–2030 (USD MILLION)       453

TABLE 569            MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       453

TABLE 570            MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET

FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)                 454

TABLE 571            MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET

FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)                 454

TABLE 572            MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET,

BY END USER, 2023–2030 (USD MILLION)               455

TABLE 573            GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            456

TABLE 574            GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION)                 456

TABLE 575            GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                457

TABLE 576            GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              457

TABLE 577            GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              457

TABLE 578            GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            458

TABLE 579            GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            458

TABLE 580            GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       458

TABLE 581            GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            459

TABLE 582            GCC COUNTRIES: OTHER VETERINARY REFERENCE LABORATORY MARKET,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       459

TABLE 583            GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)         459

TABLE 584            GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)         460

TABLE 585            GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET,

BY APPLICATION, 2023–2030 (USD MILLION)       460

TABLE 586            GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            461

TABLE 587            GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET

FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)                 461

TABLE 588            GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET

FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)                 461

TABLE 589            GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET,

BY END USER, 2023–2030 (USD MILLION)               462

TABLE 590            KINGDOM OF SAUDI ARABIA: KEY MACROINDICATORS      462

TABLE 591            KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET,

BY SERVICE, 2023–2030 (USD MILLION)  463

TABLE 592            KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       463

TABLE 593            KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            464

TABLE 594            KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                 464

TABLE 595            KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              464

TABLE 596            KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              465

TABLE 597            KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                 465

TABLE 598            KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              465

TABLE 599            KINGDOM OF SAUDI ARABIA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                466

TABLE 600            KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)                 466

TABLE 601            KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)   466

TABLE 602            KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET,

BY APPLICATION, 2023–2030 (USD MILLION)       467

TABLE 603            KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       467

TABLE 604            KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET

FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)                 468

TABLE 605            KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET

FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)                 468

TABLE 606            KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET,

BY END USER, 2023–2030 (USD MILLION)               469

TABLE 607            UAE: KEY MACROINDICATORS  469

TABLE 608            UAE: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,

2023–2030 (USD MILLION)            470

TABLE 609            UAE: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL

CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                 470

TABLE 610            UAE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       470

TABLE 611            UAE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            471

TABLE 612            UAE: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       471

TABLE 613            UAE: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       471

TABLE 614            UAE: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                472

TABLE 615            UAE: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       472

TABLE 616            UAE: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            472

TABLE 617            UAE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION) 473

TABLE 618            UAE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)       473

TABLE 619            UAE: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            474

TABLE 620            UAE: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            474

TABLE 621            UAE: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            475

TABLE 622            UAE: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            475

TABLE 623            UAE: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,

2023–2030 (USD MILLION)            476

TABLE 624            REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET,

BY SERVICE, 2023–2030 (USD MILLION)  476

TABLE 625            REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET

FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            477

TABLE 626            REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET

FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            477

TABLE 627            REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET

FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 477

TABLE 628            REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET

FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            478

TABLE 629            REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET

FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                 478

TABLE 630            REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                 478

TABLE 631            REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET

FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            479

TABLE 632            REST OF GCC COUNTRIES: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       479

TABLE 633            REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET

FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)            479

TABLE 634            REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)   480

TABLE 635            REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET,

BY APPLICATION, 2023–2030 (USD MILLION)       480

TABLE 636            REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)     481

TABLE 637            REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET

FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)                 481

TABLE 638            REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET

FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)                 481

TABLE 639            REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET,

BY END USER, 2023–2030 (USD MILLION)               482

TABLE 640            REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION) 483

TABLE 641            REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       483

TABLE 642            REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            484

TABLE 643            REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                 484

TABLE 644            REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              484

TABLE 645            REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              485

TABLE 646            REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY

MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            485

TABLE 647            REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)              485

TABLE 648            REST OF MIDDLE EAST & AFRICA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)                486

TABLE 649            REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)                 486

TABLE 650            REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)   486

TABLE 651            REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)       487

TABLE 652            REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)       487

TABLE 653            REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)         488

TABLE 654            REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)         488

TABLE 655            REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION) 489

TABLE 656            OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VETERINARY REFERENCE LABORATORY MARKET                 490

TABLE 657            GLOBAL VETERINARY REFERENCE LABORATORY MARKET:

DEGREE OF COMPETITION         496

TABLE 658            US VETERINARY REFERENCE LABORATORY MARKET: DEGREE OF COMPETITION    497

TABLE 659            VETERINARY REFERENCE LABORATORY MARKET: REGION FOOTPRINT 501

TABLE 660            VETERINARY REFERENCE LABORATORY MARKET: SERVICE FOOTPRINT 502

TABLE 661            VETERINARY REFERENCE LABORATORY MARKET: ANIMAL TYPE FOOTPRINT      503

TABLE 662            VETERINARY REFERENCE LABORATORY MARKET: DETAILED

LIST OF KEY STARTUPS/SME PLAYERS  506

TABLE 663            VETERINARY REFERENCE LABORATORY MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS, BY PRODUCT AND REGION   507

TABLE 664            VETERINARY REFERENCE LABORATORY MARKET: SERVICE LAUNCHES & ENHANCEMENTS, JANUARY 2022−SEPTEMBER 2025 510

TABLE 665            VETERINARY REFERENCE LABORATORY MARKET: DEALS,

JANUARY 2022−SEPTEMBER 2025              512

TABLE 666            VETERINARY REFERENCE LABORATORY MARKET: EXPANSIONS,

JANUARY 2022–SEPTEMBER 2025                513

TABLE 667            VETERINARY REFERENCE LABORATORY MARKET: OTHER DEVELOPMENTS, JANUARY 2022−SEPTEMBER 2025 514

TABLE 668            IDEXX LABORATORIES, INC.: COMPANY OVERVIEW          515

TABLE 669            IDEXX LABORATORIES, INC.: SERVICES OFFERED             517

TABLE 670            IDEXX LABORATORIES, INC.: SERVICE LAUNCHES AND ENHANCEMENTS,

JANUARY 2022−SEPTEMBER 2025              520

TABLE 671            MARS, INCORPORATED: COMPANY OVERVIEW                 523

TABLE 672            MARS, INCORPORATED: SERVICES OFFERED                 524

TABLE 673            MARS, INCORPORATED: SERVICE LAUNCHES, JANUARY 2022–SEPTEMBER 2025                526

TABLE 674            MARS, INCORPORATED: DEALS, JANUARY 2022−SEPTEMBER 2025 526

TABLE 675            MARS, INCORPORATED: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025   527

TABLE 676            ZOETIS SERVICES LLC: COMPANY OVERVIEW                 529

TABLE 677            ZOETIS SERVICES LLC: SERVICES OFFERED                 531

TABLE 678            ZOETIS SERVICES LLC: DEALS, JANUARY 2022−SEPTEMBER 2025 533

TABLE 679            ZOETIS SERVICES LLC: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025   534

TABLE 680            GD (ROYAL GD ANIMAL HEALTH): COMPANY OVERVIEW          536

TABLE 681            GD (ROYAL GD ANIMAL HEALTH): SERVICES OFFERED             537

TABLE 682            GD (ROYAL GD ANIMAL HEALTH): SERVICE LAUNCHES,

JANUARY 2022–SEPTEMBER 2025                543

TABLE 683            GD (ROYAL GD ANIMAL HEALTH): DEALS, JANUARY 2022−SEPTEMBER 2025              544

TABLE 684          GD (ROYAL GD ANIMAL HEALTH): EXPANSIONS, JANUARY 2022–SEPTEMBER 2025                545

TABLE 685            LABOKLIN GMBH & CO. KG: COMPANY OVERVIEW          547

TABLE 686            LABOKLIN GMBH & CO. KG: SERVICES OFFERED                 547

TABLE 687            LABOKLIN GMBH & CO. KG: SERVICE LAUNCHES,

JANUARY 2022–SEPTEMBER 2025                549

TABLE 688            CVS (UK) LIMITED: COMPANY OVERVIEW                 551

TABLE 689            CVS (UK) LIMITED: SERVICES OFFERED 553

TABLE 690            CVS (UK) LIMITED: SERVICE LAUNCHES, JANUARY 2022–SEPTEMBER 2025                556

TABLE 691            NATIONAL VETERINARY SERVICES LABORATORY USDA-APHIS:

COMPANY OVERVIEW   557

TABLE 692            NATIONAL VETERINARY SERVICES LABORATORY USDA-APHIS: SERVICES OFFERED               557

TABLE 693            ANIMAL AND PLANT HEALTH AGENCY: COMPANY OVERVIEW   559

TABLE 694            ANIMAL AND PLANT HEALTH AGENCY: SERVICES OFFERED        559

TABLE 695            ANIMAL AND PLANT HEALTH AGENCY: OTHER DEVELOPMENTS, JANUARY 2022−SEPTEMBER 2025         561

TABLE 696            ICAR–NIVEDI (NATIONAL INSTITUTE OF VETERINARY EPIDEMIOLOGY

AND DISEASE INFORMATICS): COMPANY OVERVIEW     562

TABLE 697            ICAR–NIVEDI (NATIONAL INSTITUTE OF VETERINARY EPIDEMIOLOGY

AND DISEASE INFORMATICS): SERVICES OFFERED          562

TABLE 698            NATIONAL VETERINARY SERVICES: COMPANY OVERVIEW          564

TABLE 699            NATIONAL VETERINARY SERVICES: SERVICES OFFERED             565

TABLE 700            NATIONAL VETERINARY SERVICES: EXPANSIONS,

JANUARY 2022–SEPTEMBER 2025                566

TABLE 701            NATIONAL VETERINARY SERVICES: OTHER DEVELOPMENTS,

JANUARY 2022−SEPTEMBER 2025              567

TABLE 702            TEXAS A&M VETERINARY MEDICAL DIAGNOSTIC LABORATORY (TVMDL):

COMPANY OVERVIEW   568

TABLE 703            TEXAS A&M VETERINARY MEDICAL DIAGNOSTIC LABORATORY (TVMDL):

SERVICES OFFERED        568

TABLE 704            TEXAS A&M VETERINARY MEDICAL DIAGNOSTIC LABORATORY (TVMDL):

SERVICE LAUNCHES AND ENHANCEMENTS, JANUARY 2022−SEPTEMBER 2025 569

TABLE 705            ANIMAL HEALTH DIAGNOSTIC CENTER, CORNELL UNIVERSITY:

COMPANY OVERVIEW   571

TABLE 706            ANIMAL HEALTH DIAGNOSTIC CENTER, CORNELL UNIVERSITY: SERVICES OFFERED        571

TABLE 707            ANIMAL HEALTH DIAGNOSTIC CENTER, CORNELL UNIVERSITY: SERVICE LAUNCHES, JANUARY 2022−SEPTEMBER 2025 573

TABLE 708            ANIMAL HEALTH DIAGNOSTIC CENTER, CORNELL UNIVERSITY: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025              574

TABLE 709            COLORADO STATE UNIVERSITY (VETERINARY DIAGNOSTIC LABORATORY): COMPANY OVERVIEW      575

TABLE 710            COLORADO STATE UNIVERSITY (VETERINARY DIAGNOSTIC LABORATORY): PRODUCTS/SERVICES OFFERED                 575

TABLE 711            BIOBEST LABORATORIES LTD.: COMPANY OVERVIEW          578

TABLE 712            BIOBEST LABORATORIES LTD.: SERVICES OFFERED             579

TABLE 713            BIOBEST LABORATORIES LTD.: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025                581

TABLE 714            PRIVATE VETERINARY CLINIC SAN MARCO SRL UNIPERSONALE:

COMPANY OVERVIEW   582

TABLE 715            PRIVATE VETERINARY CLINIC SAN MARCO SRL UNIPERSONALE:

SERVICES OFFERED        582

TABLE 716            ROYAL VETERINARY COLLEGE, UNIVERSITY OF LONDON: COMPANY OVERVIEW              584

TABLE 717            UNIVERSITY OF GUELPH, ANIMAL HEALTH LABORATORY: COMPANY OVERVIEW    585

TABLE 718            VAXXINOVA: COMPANY OVERVIEW        586

TABLE 719            MIRA VISTA LABS: COMPANY OVERVIEW                 588

TABLE 720            ELLIE DIAGNOSTICS: COMPANY OVERVIEW                 589

TABLE 721            PROTATEK INTERNATIONAL, INC.: COMPANY OVERVIEW          590

TABLE 722            THE PIRBRIGHT INSTITUTE: COMPANY OVERVIEW          591

TABLE 723            CVR LABORATORY (CVRL): COMPANY OVERVIEW          592

TABLE 724            VETERINARY PATHOLOGY GROUP: COMPANY OVERVIEW          593

TABLE 725            FRIEDRICH-LOEFFLER-INSTITUT (FLI): COMPANY OVERVIEW   594

LIST OF FIGURES

FIGURE 1              VETERINARY REFERENCE LABORATORY MARKET SEGMENTATION           49

FIGURE 2              VETERINARY REFERENCE LABORATORY MARKET: REGIONAL SCOPE       50

FIGURE 3              VETERINARY REFERENCE LABORATORY MARKET: YEARS CONSIDERED  51

FIGURE 4              VETERINARY REFERENCE LABORATORY MARKET: RESEARCH DESIGN     54

FIGURE 5              VETERINARY REFERENCE LABORATORY MARKET:

KEY DATA FROM SECONDARY SOURCES               57

FIGURE 6              VETERINARY REFERENCE LABORATORY MARKET: KEY PRIMARY SOURCES            58

FIGURE 7              VETERINARY REFERENCE LABORATORY MARKET:

KEY DATA FROM PRIMARY SOURCES     59

FIGURE 8              VETERINARY REFERENCE LABORATORY MARKET: KEY INDUSTRY INSIGHTS        60

FIGURE 9              BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION                60

FIGURE 10            BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE):

BY END USER, DESIGNATION, AND REGION        61

FIGURE 11            BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND

DEMAND-SIDE PARTICIPANTS  61

FIGURE 12            VETERINARY REFERENCE LABORATORY MARKET SIZE APPROACH:

REVENUE SHARE ANALYSIS         62

FIGURE 13            VETERINARY REFERENCE LABORATORY MARKET: REVENUE SHARE ANALYSIS ILLUSTRATION FOR IDEXX LABORATORIES, INC. (2024)           63

FIGURE 14            REVENUE ANALYSIS OF TOP FIVE COMPANIES IN VETERINARY REFERENCE LABORATORY MARKET (2024)                 63

FIGURE 15            VETERINARY DIAGNOSTICS MARKET: DEMAND-SIDE ANALYSIS             65

FIGURE 16            VETERINARY REFERENCE LABORATORY MARKET: TOP-DOWN APPROACH            65

FIGURE 17            VETERINARY REFERENCE LABORATORY MARKET: BOTTOM-UP APPROACH          66

FIGURE 18            DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN VETERINARY REFERENCE LABORATORY MARKET (2025–2030)       67

FIGURE 19            VETERINARY REFERENCE LABORATORY MARKET: CAGR PROJECTIONS  67

FIGURE 20            VETERINARY REFERENCE LABORATORY MARKET:

DATA TRIANGULATION METHODOLOGY            69

FIGURE 21            VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,

2025 VS. 2030 (USD MILLION)      73

FIGURE 22            VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION,

2025 VS. 2030 (USD MILLION)      74

FIGURE 23            VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE,

2025 VS. 2030 (USD MILLION)      74

FIGURE 24            COMPANION ANIMALS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)                75

FIGURE 25            LIVESTOCK ANIMALS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)                76

FIGURE 26            VETERINARY REFERENCE LABORATORY MARKET, BY END USER,

2025 VS. 2030 (USD MILLION)      76

FIGURE 27            GEOGRAPHIC SNAPSHOT OF VETERINARY REFERENCE LABORATORY MARKET       77

FIGURE 28            INCREASING INCIDENCE OF CHRONIC CONDITIONS TO FUEL MARKET GROWTH           78

FIGURE 29            CHINA AND CONSUMABLES COMMANDED LARGEST MARKET SHARE IN 2024             79

FIGURE 30            ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD       80

FIGURE 31            CHINA TO REGISTER HIGHEST GROWTH RATE DURING STUDY PERIOD               80

FIGURE 32            EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES FROM

2025 TO 2030       81

FIGURE 33            VETERINARY REFERENCE LABORATORY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    83

FIGURE 34            EUROPE: PET POPULATION (DOGS VS. CATS), 2021–2023 (MILLION)      89

FIGURE 35            US: PET EXPENDITURE, DOGS VS. CATS, 2024 (USD)    91

FIGURE 36            VETERINARY REFERENCE LABORATORY MARKET: PORTER’S

FIVE FORCES ANALYSIS 102

FIGURE 37            INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY REFERENCE LABORATORIES                105

FIGURE 38            KEY BUYING CRITERIA FOR TOP THREE END USERS   106

FIGURE 39            NUMBER OF GRANTED PATENT APPLICATIONS IN VETERINARY REFERENCE LABORATORY MARKET (JANUARY 2014–SEPTEMBER 2025) 112

FIGURE 40            TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY REFERENCE LABORATORY PATENTS (JANUARY 2014–OCTOBER 2025)      113

FIGURE 41            AVERAGE SELLING PRICE TREND OF IMMUNODIAGNOSTIC AND URINALYSIS SERVICES, BY KEY PLAYER (2024)   116

FIGURE 42            AVERAGE SELLING PRICE OF CLINICAL CHEMISTRY AND IMMUNODIAGNOSTIC SERVICES, BY REGION (2024)    117

FIGURE 43            AI-USE CASES IN VETERINARY REFERENCE LABORATORY MARKET 125

FIGURE 44            VETERINARY REFERENCE LABORATORY MARKET: ECOSYSTEM MAP         127

FIGURE 45            VETERINARY REFERENCE LABORATORY MARKET: VALUE CHAIN ANALYSIS           129

FIGURE 46            FUNDING AND NUMBER OF DEALS IN VETERINARY REFERENCE LABORATORY MARKET, 2020-2024 (USD MILLION) 131

FIGURE 47            TRENDS/DISRUPTIONS INFLUENCING CUSTOMERS’ CUSTOMERS IN VETERINARY REFERENCE LABORATORY MARKET 134

FIGURE 48            ANNUAL PER CAPITA MEAT CONSUMPTION PROJECTIONS, DEVELOPING VS. DEVELOPED COUNTRIES, 2020–2030              242

FIGURE 49            VETERINARY REFERENCE LABORATORY MARKET: GEOGRAPHIC SNAPSHOT        265

FIGURE 50            NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET SNAPSHOT         267

FIGURE 51            US: POPULATION OF DOGS, 2012–2022 (MILLION)           274

FIGURE 52            ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET SNAPSHOT         346

FIGURE 53            REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY REFERENCE LABORATORY MARKET (2020−2024)                 493

FIGURE 54            RANKING OF KEY PLAYERS IN GLOBAL VETERINARY SOFTWARE MARKET, 2024                 494

FIGURE 55            GLOBAL VETERINARY REFERENCE LABORATORY MARKET SHARE ANALYSIS (2024)                 496

FIGURE 56            US: VETERINARY REFERENCE LABORATORY MARKET SHARE ANALYSIS, BY KEY PLAYER (2024)             497

FIGURE 57            VETERINARY REFERENCE LABORATORY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024                 499

FIGURE 58            VETERINARY REFERENCE LABORATORY MARKET: COMPANY FOOTPRINT             500

FIGURE 59            VETERINARY REFERENCE LABORATORY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024        505

FIGURE 60            VETERINARY REFERENCE LABORATORY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 508

FIGURE 61            R&D EXPENDITURE OF KEY PLAYERS IN VETERINARY REFERENCE LABORATORY MARKET, 2022−2024                 509

FIGURE 62            EV/EBITDA OF KEY VENDORS   509

FIGURE 63            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR

STOCK BETA OF KEY VENDORS 510

FIGURE 64            IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT          516

FIGURE 65            ZOETIS SERVICES LLC: COMPANY SNAPSHOT                 530

FIGURE 66            CVS (UK) LIMITED: COMPANY SNAPSHOT                 552

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧